In our experiences with commercial MDA-MB-231 xenografting (http://altogenlabs.com/xenograft-models/breast-cancer-xenograft/mda-mb-231-xenograft-model/) the xenografts do have good growth patterns, but can be tricky to deal with. It does match your desired characteristics, and would be an excellent choice if you already know what kind of xenograft study you would like to run.
MDA-MB-231 is certainly one of the most widely used cell lines, and has the advantage of spontaneously metastasizing from the mammary fat pad of nod/scid mice in orthotopic models; see, for example:
MDA-MB-231 definitely, not only triple-negative, fast growing and invasive, but p53 mutant.
You'll probably need another (control) triple-negative, but p53 wild type cell line. I know that MCF-7 is p53 wild type, but express estrogen receptor. However, try to find if any of ATCC triple negative cell lines (https://www.lgcstandards-atcc.org/Products/All/TCP-1003?geo_country=rs) is p53 wild type.
In our experiences with commercial MDA-MB-231 xenografting (http://altogenlabs.com/xenograft-models/breast-cancer-xenograft/mda-mb-231-xenograft-model/) the xenografts do have good growth patterns, but can be tricky to deal with. It does match your desired characteristics, and would be an excellent choice if you already know what kind of xenograft study you would like to run.